StockDriftsStockDriftsTop 4 Lunate Holding Rsc Ltd Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 45.54% | 2.20M | $96.1M | new | — | 2024-12-31 | |
| BIRK | BIRKENSTOCK HOLDING PLC | 27.13% | 1.01M | $57.2M | new | — | 2024-12-31 | |
| LINE | LINEAGE INC | 16.66% | 600.0K | $35.1M | new | — | 2024-12-31 | |
| NMRA | NEUMORA THERAPEUTICS INC. | 10.67% | 2.12M | $22.5M | new | — | 2024-12-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — |
| Top 20 Holdings Unweighted | — | — | — | — |
Lunate Holding Rsc Ltd reports $210.95M in US-listed equity holdings across 4 positions in its most recent 13F filing. Its largest disclosed positions are RVMD (45.5%), BIRK (27.1%) and LINE (16.7%). Figures reflect the Q4 2024 filing.
Sign up free to track Lunate Holding Rsc Ltd, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Lunate Holding Rsc Ltd’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2009522). View Lunate Holding Rsc Ltd’s 13F filings on SEC